Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...
TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...
Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...
Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...
Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...
RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...
Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...
Singapore-based SCG Cell Therapy Pte Ltd, a leading biotechnology company, announced that the China National Medic...
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...
Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...
Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...
Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...
